New
Vitiligo Clinical Trials update
Clinical trials are experiments that test how well new drugs, treatments or devices work in people. Trials progress through Phases I-IV to test a drug candidate, find the appropriate dosage, and look for side effects. The goal is to determine whether a medicine is both safe and effective. Drug candidates that have entered into clinical trials or pending approval by the U.S. Food and Drug Administration (FDA) are often said to be "in the pipeline."
Our Trials Hub provides a comprehensive list of more than 20 active clinical trials located in Bangladesh, Canada, Egypt, France, Israel, and the United States.
👉 UPDATE February 6, 2023: New study posted "A Phase 1, Single and Multiple Ascending Dose (SAD/MAD) Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of VYN201 in Healthy Volunteers and in Subjects with Non-Segmental Vitiligo (NSV)" from Vyne Therapeutics.
Our CEO Yan Valle analyzes and monitors the entire drug development landscape along with the trends shaping and driving the vitiligo market, and reports findings in Vitiligo Drug Pipeline Analysis and Market Insights.
FAQOther Questions
- Does halo nevi affect vitiligo development?
Halo nevi (also known as Sutton's nevi) are characterized by a mole that's surrounded by a ring of depigmented or lighter skin. While both halo nevi and vitiligo involve the des...
- Who is prone to vitiligo?
Vitiligo can affect anyone, regardless of gender, age, or race. Vitiligo prevalence is between 0.76% and 1.11% of the U.S. population, including around 40% of those with the con...
- Vitiligo trials for kids: basics for the parents
Pediatric vitiligo trials · The basics Two parallel studies are evaluating investigational use of ruxolitinib cream in young children — researchers are still finding out how wel...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.